Immediate Impact
6 standout
Citing Papers
Targeting TIGIT for cancer immunotherapy: recent advances and future directions
2024 Standout
Radiotherapy combined with immunotherapy: the dawn of cancer treatment
2022 Standout
Works of Arnaud Bayle being referenced
Switch to anti-programmed cell death protein 1 (anti-PD-1) fixed-dose regimen: What is the economic impact?
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Arnaud Bayle | 80 | 31 | 11 | 51 | 15 | 153 | |
| Tariq U. Azam | 110 | 20 | 21 | 26 | 15 | 223 | |
| Claudia Brusadelli | 86 | 13 | 11 | 23 | 9 | 173 | |
| Anath Flugelman | 110 | 12 | 15 | 38 | 20 | 172 | |
| Diana Žaliaduonytė | 55 | 8 | 19 | 19 | 22 | 146 | |
| Omar Al Omari | 18 | 8 | 15 | 36 | 20 | 131 | |
| Wolfgang Gleiber | 86 | 10 | 18 | 130 | 20 | 209 | |
| Zayd Tippu | 117 | 7 | 18 | 63 | 13 | 222 | |
| Viviana Pineda | 44 | 27 | 4 | 17 | 19 | 234 | |
| Sara Bosio | 72 | 8 | 8 | 14 | 14 | 141 | |
| Fauzia Riaz | 77 | 10 | 12 | 31 | 16 | 153 |
All Works
Login with ORCID to disown or claim papers
Loading papers...